Literature DB >> 19490804

Effect of L-ascorbate on chloride transport in freshly excised sinonasal epithelia.

Do-Yeon Cho1, Peter H Hwang, Beate Illek.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) occurs at high frequency in patients with cystic fibrosis, suggesting that the cystic fibrosis transmembrane conductance regulator (CFTR) chloride (Cl) ion channel might be involved in the development of chronic sinusitis in the general population. CFTR Cl ion transport controls the hydration of mucosal surfaces and promotes effective mucociliary clearance. Altered ion transport and, hence, disrupted mucociliary function, could play a role in the pathogenesis of sinus disease. L-ascorbate is a metabolically active component of the nasal and tracheobronchial airway lining fluids and appears to serve as an important biological effector of CFTR-mediated chloride secretion. The purpose of this study was to determine the effects of L-ascorbate on Cl ion transport in freshly excised sinonasal epithelia from normal controls and patients with CRS.
METHODS: Four different types of sinonasal tissue (normal sinus mucosa, sinus mucosa from CRS, normal nasal mucosa, nasal mucosa from CRS) were obtained during endoscopic sinus surgery and mounted on sliders with open areas of 0.03-0.71 cm2 between Ussing hemichambers. Short-circuit current (Isc) was continuously recorded, and a serosa-to-mucosa-directed Cl gradient was applied to increase the electrochemical driving force.
RESULTS: L-ascorbate (500 microM) stimulated Cl currents (DeltaI(Cl), microA/cm2) across sinonasal epithelia from normal and CRS patients. The Cl secretory response to L-ascorbate was effectively blocked by the Cl ion transport inhibitors glibenclamide and bumetanide. A maximal dose of L-ascorbate (at 1 mM) stimulated 53-70% of Cl currents elicited by the cAMP agonist forskolin. CRS sinonasal tissue was characterized by impaired Cl secretory responses to L-ascorbate that were reduced by 33% in sinus epithelial tissue and by 70% in nasal epithelial tissue when compared with normal subjects. In nasal epithelial tissue from normal subjects, Cl secretion was approximately twofold increased when compared with sinus epithelial tissue. In contrast, nasal versus sinus epithelial tissue from CRS patients showed no differences.
CONCLUSION: Topical administration of L-ascorbate to freshly excised sinus and nasal mucosa enhances chloride secretion. Given that decreased CFTR-mediated Cl secretion may contribute to the development of CRS, L-ascorbate may offer potential as a therapeutic agent for the improvement of mucociliary clearance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490804      PMCID: PMC3196350          DOI: 10.2500/ajra.2009.23.3316

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  15 in total

Review 1.  Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology.

Authors:  Michael S Benninger; Berrylin J Ferguson; James A Hadley; Daniel L Hamilos; Michael Jacobs; David W Kennedy; Donald C Lanza; Bradley F Marple; J David Osguthorpe; James A Stankiewicz; Jack Anon; James Denneny; Ivor Emanuel; Howard Levine
Journal:  Otolaryngol Head Neck Surg       Date:  2003-09       Impact factor: 3.497

2.  Ascorbic acid in nasal and tracheobronchial airway lining fluids.

Authors:  Bettina C Schock; John Koostra; Sunye Kwack; Robert M Hackman; Albert Van Der Vliet; Carroll E Cross
Journal:  Free Radic Biol Med       Date:  2004-11-01       Impact factor: 7.376

3.  Antioxidants in bronchoalveolar lavage fluid cells isolated from ozone--exposed normal and ascorbate-deficient guinea pigs.

Authors:  U P Kodavanti; D L Costa; J Richards; K M Crissman; R Slade; G E Hatch
Journal:  Exp Lung Res       Date:  1996 Jul-Aug       Impact factor: 2.459

4.  Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.

Authors:  M Levine; C Conry-Cantilena; Y Wang; R W Welch; P W Washko; K R Dhariwal; J B Park; A Lazarev; J F Graumlich; J King; L R Cantilena
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  Compromised concentrations of ascorbate in fluid lining the respiratory tract in human subjects after exposure to ozone.

Authors:  I S Mudway; M T Krishna; A J Frew; D MacLeod; T Sandstrom; S T Holgate; F J Kelly
Journal:  Occup Environ Med       Date:  1999-07       Impact factor: 4.402

6.  Serum levels of antioxidant vitamins, copper, zinc and magnesium in children with chronic rhinosinusitis.

Authors:  Murat Unal; Lülüfer Tamer; Yavuz Selim Pata; Serkan Kilic; Ulaş Degirmenci; Yücel Akbaş; Kemal Görür; Uğur Atik
Journal:  J Trace Elem Med Biol       Date:  2004       Impact factor: 3.849

7.  Transient receptor potential vanilloid type 4 channel expression in chronic rhinosinusitis.

Authors:  Geeta Bhargave; Bradford A Woodworth; Guoxiang Xiong; Steven G Wolfe; Marcelo B Antunes; Noam A Cohen
Journal:  Am J Rhinol       Date:  2008 Jan-Feb

8.  Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man.

Authors:  M Nishikimi; R Fukuyama; S Minoshima; N Shimizu; K Yagi
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

Review 9.  Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosis.

Authors:  Marcus Mall; Stephanie Hirtz; Tanja Gonska; Karl Kunzelmann
Journal:  J Cyst Fibros       Date:  2004-08       Impact factor: 5.482

10.  Comparison of antioxidant substances in bronchoalveolar lavage cells and fluid from humans, guinea pigs, and rats.

Authors:  R Slade; K Crissman; J Norwood; G Hatch
Journal:  Exp Lung Res       Date:  1993 Jul-Aug       Impact factor: 2.459

View more
  7 in total

1.  Herbal dry extract BNO 1011 improves clinical and mucociliary parameters in a rabbit model of chronic rhinosinusitis.

Authors:  Do-Yeon Cho; Daniel Skinner; Calvin Mackey; Harold B Lampkin; Jeffrey Brent Elder; Dong Jin Lim; Shaoyan Zhang; Justin McCormick; Guillermo J Tearney; Steven M Rowe; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2019-01-18       Impact factor: 3.858

2.  Characteristics of chloride transport in nasal mucosa from patients with primary ciliary dyskinesia.

Authors:  Do-Yeon Cho; Peter H Hwang; Beate Illek
Journal:  Laryngoscope       Date:  2010-07       Impact factor: 3.325

3.  Novel Therapy of Bicarbonate, Glutathione, and Ascorbic Acid Improves Cystic Fibrosis Mucus Transport.

Authors:  Adegboyega Timothy Adewale; Emily Falk Libby; Lianwu Fu; Andrew Lenzie; Evan R Boitet; Susan E Birket; Courtney Fernandez Petty; J Dixon Johns; Marina Mazur; Guillermo J Tearney; Dan Copeland; Carolyn Durham; Steven M Rowe
Journal:  Am J Respir Cell Mol Biol       Date:  2020-09       Impact factor: 6.914

Review 4.  Acquired cystic fibrosis transmembrane conductance regulator dysfunction.

Authors:  Catherine Banks; Laura Freeman; Do Yeon Cho; Bradford A Woodworth
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-10-31

5.  Korean Red Ginseng aqueous extract improves markers of mucociliary clearance by stimulating chloride secretion.

Authors:  Do-Yeon Cho; Daniel Skinner; Shaoyan Zhang; Ahmed Lazrak; Dong Jin Lim; Christopher G Weeks; Catherine G Banks; Chang Kyun Han; Si-Kwan Kim; Guillermo J Tearney; Sadis Matalon; Steven M Rowe; Bradford A Woodworth
Journal:  J Ginseng Res       Date:  2019-09-13       Impact factor: 6.060

6.  The effects of vitamins C and B12 on human nasal ciliary beat frequency.

Authors:  Jian Jiao; Na Meng; Hong Wang; Luo Zhang
Journal:  BMC Complement Altern Med       Date:  2013-05-20       Impact factor: 3.659

7.  Sinus Microanatomy and Microbiota in a Rabbit Model of Rhinosinusitis.

Authors:  Do-Yeon Cho; Calvin Mackey; William J Van Der Pol; Daniel Skinner; Casey D Morrow; Trenton R Schoeb; Steven M Rowe; William E Swords; Guillermo J Tearney; Bradford A Woodworth
Journal:  Front Cell Infect Microbiol       Date:  2018-01-12       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.